
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.2.3, mkdocs-material-7.3.4">
    
    
      
        <title>SLE - CNUH.Rheumatology</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.db9e7362.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.3f5d1f46.min.css">
        
      
    
    
    
      
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato:300,400,400i,700%7C&display=fallback">
        <style>:root{--md-text-font-family:"Lato";--md-code-font-family:""}</style>
      
    
    
    
      <link rel="stylesheet" href="../../stylesheets/extra.css">
    
      <link rel="stylesheet" href="../../stylesheets/table_style.css">
    
    
      


    
    
  </head>
  
  
    
    
    
    
    
    <body dir="ltr" data-md-color-scheme="" data-md-color-primary="" data-md-color-accent="indigo">
  
    
    <script>function __prefix(e){return new URL("../..",location).pathname+"."+e}function __get(e,t=localStorage){return JSON.parse(t.getItem(__prefix(e)))}</script>
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#1" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="CNUH.Rheumatology" class="md-header__button md-logo" aria-label="CNUH.Rheumatology" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54z"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            CNUH.Rheumatology
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              SLE
            
          </span>
        </div>
      </div>
    </div>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5z"/></svg>
      </label>
      
<div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5z"/></svg>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" aria-label="Clear" tabindex="-1">
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-tabs__inner md-grid">
    <ul class="md-tabs__list">
      
        
  
  


  <li class="md-tabs__item">
    <a href="../.." class="md-tabs__link">
      Home
    </a>
  </li>

      
        
  
  
    
  


  
  
  
    

  
  
  
    <li class="md-tabs__item">
      <a href="../../intro/approach/" class="md-tabs__link md-tabs__link--active">
        Docs
      </a>
    </li>
  

  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="CNUH.Rheumatology" class="md-nav__button md-logo" aria-label="CNUH.Rheumatology" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54z"/></svg>

    </a>
    CNUH.Rheumatology
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
      

  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        Home
      </a>
    </li>
  

    
      
      
      

  
  
    
  
  
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
      
        <input class="md-nav__toggle md-toggle" data-md-toggle="__nav_2" type="checkbox" id="__nav_2" checked>
      
      
      
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
          
        
      
      
        <label class="md-nav__link" for="__nav_2">
          Docs
          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <nav class="md-nav" aria-label="Docs" data-md-level="1">
        <label class="md-nav__title" for="__nav_2">
          <span class="md-nav__icon md-icon"></span>
          Docs
        </label>
        <ul class="md-nav__list" data-md-scrollfix>
          
            
              
  
  
  
    
    <li class="md-nav__item md-nav__item--nested">
      
      
        <input class="md-nav__toggle md-toggle" data-md-toggle="__nav_2_1" type="checkbox" id="__nav_2_1" >
      
      
      
        
          
        
          
        
          
        
      
      
        <label class="md-nav__link" for="__nav_2_1">
          Introduction
          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <nav class="md-nav" aria-label="Introduction" data-md-level="2">
        <label class="md-nav__title" for="__nav_2_1">
          <span class="md-nav__icon md-icon"></span>
          Introduction
        </label>
        <ul class="md-nav__list" data-md-scrollfix>
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../intro/approach/" class="md-nav__link">
        Approach
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../intro/criteria/" class="md-nav__link">
        Criteria
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../intro/div/" class="md-nav__link">
        div
      </a>
    </li>
  

            
          
        </ul>
      </nav>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../approach/" class="md-nav__link">
        Dx. Tests & Meds
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../ra/ra/" class="md-nav__link">
        Rheumatoid Arthritis
      </a>
    </li>
  

            
          
            
              
  
  
    
  
  
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
      
        <input class="md-nav__toggle md-toggle" data-md-toggle="__nav_2_4" type="checkbox" id="__nav_2_4" checked>
      
      
      
        
          
        
          
        
      
      
        <label class="md-nav__link" for="__nav_2_4">
          SLE & APS 
          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <nav class="md-nav" aria-label="SLE & APS " data-md-level="2">
        <label class="md-nav__title" for="__nav_2_4">
          <span class="md-nav__icon md-icon"></span>
          SLE & APS 
        </label>
        <ul class="md-nav__list" data-md-scrollfix>
          
            
              
  
  
    
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" data-md-toggle="toc" type="checkbox" id="__toc">
      
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          SLE
          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="./" class="md-nav__link md-nav__link--active">
        SLE
      </a>
      
        
<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1" class="md-nav__link">
    1. 역학 및 발병 인자
  </a>
  
    <nav class="md-nav" aria-label="1. 역학 및 발병 인자">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#1-1" class="md-nav__link">
    1-1. 역학
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2" class="md-nav__link">
    2. 병인기전
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3" class="md-nav__link">
    3. 임상증상
  </a>
  
    <nav class="md-nav" aria-label="3. 임상증상">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#3-1" class="md-nav__link">
    3-1. 관절증상
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#3-2" class="md-nav__link">
    3-2. 관절 외 증상
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4" class="md-nav__link">
    4. 검사소견과 진단
  </a>
  
    <nav class="md-nav" aria-label="4. 검사소견과 진단">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#4-1" class="md-nav__link">
    4-1. 혈액/소변검사
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#4-2" class="md-nav__link">
    4-2. 조직검사
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#4-3" class="md-nav__link">
    4-3. 분류기준
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#4-4" class="md-nav__link">
    4-4. 감별진단
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5" class="md-nav__link">
    5. 치료원칙
  </a>
  
    <nav class="md-nav" aria-label="5. 치료원칙">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#5-1" class="md-nav__link">
    5-1. 개념 요약
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#5-2" class="md-nav__link">
    5-2. 가이드라인
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#5-3-disease-activity-assessment" class="md-nav__link">
    5-3. Disease activity assessment
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#5-4-damage-assessment" class="md-nav__link">
    5-4. Damage assessment
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6" class="md-nav__link">
    6. 경과와 예후
  </a>
  
    <nav class="md-nav" aria-label="6. 경과와 예후">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#6-1" class="md-nav__link">
    6-1. 예후
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../aps/" class="md-nav__link">
        APS
      </a>
    </li>
  

            
          
        </ul>
      </nav>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../sjogren/ss/" class="md-nav__link">
        Sjögren's syndrome
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../SSc/ssc/" class="md-nav__link">
        Systemic Sclerosis
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../myopathy/iim/" class="md-nav__link">
        Idiopathic Inflammatory Myositis
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../spondyloarthropathy/spa/" class="md-nav__link">
        Spondylooarthropathy
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../vasculitis/vasculitis/" class="md-nav__link">
        Vasculitis
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../crystalopathy/gout/" class="md-nav__link">
        Crystalopathy
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../pain/pain/" class="md-nav__link">
        Pain
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../other_diseases/others/" class="md-nav__link">
        Other diseases
      </a>
    </li>
  

            
          
            
              
  
  
  
    <li class="md-nav__item">
      <a href="../../misc/misc/" class="md-nav__link">
        Miscellaneous
      </a>
    </li>
  

            
          
        </ul>
      </nav>
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    
<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1" class="md-nav__link">
    1. 역학 및 발병 인자
  </a>
  
    <nav class="md-nav" aria-label="1. 역학 및 발병 인자">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#1-1" class="md-nav__link">
    1-1. 역학
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2" class="md-nav__link">
    2. 병인기전
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3" class="md-nav__link">
    3. 임상증상
  </a>
  
    <nav class="md-nav" aria-label="3. 임상증상">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#3-1" class="md-nav__link">
    3-1. 관절증상
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#3-2" class="md-nav__link">
    3-2. 관절 외 증상
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4" class="md-nav__link">
    4. 검사소견과 진단
  </a>
  
    <nav class="md-nav" aria-label="4. 검사소견과 진단">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#4-1" class="md-nav__link">
    4-1. 혈액/소변검사
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#4-2" class="md-nav__link">
    4-2. 조직검사
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#4-3" class="md-nav__link">
    4-3. 분류기준
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#4-4" class="md-nav__link">
    4-4. 감별진단
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5" class="md-nav__link">
    5. 치료원칙
  </a>
  
    <nav class="md-nav" aria-label="5. 치료원칙">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#5-1" class="md-nav__link">
    5-1. 개념 요약
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#5-2" class="md-nav__link">
    5-2. 가이드라인
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#5-3-disease-activity-assessment" class="md-nav__link">
    5-3. Disease activity assessment
  </a>
  
</li>
        
          <li class="md-nav__item">
  <a href="#5-4-damage-assessment" class="md-nav__link">
    5-4. Damage assessment
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6" class="md-nav__link">
    6. 경과와 예후
  </a>
  
    <nav class="md-nav" aria-label="6. 경과와 예후">
      <ul class="md-nav__list">
        
          <li class="md-nav__item">
  <a href="#6-1" class="md-nav__link">
    6-1. 예후
  </a>
  
</li>
        
      </ul>
    </nav>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          <div class="md-content" data-md-component="content">
            <article class="md-content__inner md-typeset">
              
                
                
                  <h1>SLE</h1>
                
                <p>전신홍반루푸스는 다양한 장기침범과 이에 따른 임상증상을 나타내며, 발병초기에 하나 또는 여러 장기를 침범할 수도 있고 질병의 경과에 따라 새로운 임상증상이 나타나기도 한다.</p>
<h2 id="1">1. 역학 및 발병 인자</h2>
<hr />
<h3 id="1-1">1-1. 역학</h3>
<table class="incidence">
   <colgroup>
    <col style="width:16%">
    <col style="width:42%">
    <col style="width:42%">
 </colgroup>
<thead>
  <tr>
    <th></th>
    <th>전세계</th>
    <th>국내</th>
  </tr>
</thead>
<tbody>
  <tr>
    <td>성비</td>
    <td colspan="2">여성 &gt; 남성 (9배)</td>
  </tr>
  <tr>
    <td>주 발병 연령</td>
    <td colspan="2">16~55세 (노인 루푸스는 증상이 가벼운 경향)</td>
  </tr>
  <tr>
    <td>유병률</td>
    <td>100명/10만 명</td>
    <td>26.5명/10만 명</td>
  </tr>
  <tr>
    <td>발병률</td>
    <td>4~7명/10만 명</td>
    <td>2.5명/10만 명</td>
  </tr>
</tbody>
</table>

<p><br></p>
<h2 id="2">2. 병인기전</h2>
<table class="basic">
<thead>
  <tr>
    <th>요인</th>
    <th>분류</th>
    <th>항목</th>
  </tr>
</thead>
<tbody>
  <tr>
    <td rowspan="2" style="background-color:rgba(0, 0, 0, 0.08)">유전적 요인</td>
    <td>보체유전자</td>
    <td>C1q, C4, C2, HLA-DR2 & DR3</td>
  </tr>
  <tr>
    <td>Fcr 수용체 이상</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="3" style="background-color:rgba(0, 0, 0, 0.08)">환경적 요인</td>
    <td>성호르몬</td>
    <td>estradiol은 지속적인 면역반응 유발, 남성호르몬은 면억억제효과</td>
  </tr>
  <tr>
    <td>감염</td>
    <td>Parvo B19, CMV, EBV</td>
  </tr>
  <tr>
    <td>기타</td>
    <td>자외선, Silica dust, 흡연, 약물 (hydralazine, procainamide, quinidine, INH, diltiazem, minocycline 등)</td>
  </tr>
<tr>
    <td rowspan="2" style="background-color:rgba(0, 0, 0, 0.04)">면역학적 요인</td>
    <td>선천면역계 이상</td>
    <td>TLR의 이상, cytokine 발현 증가, 보체 이상</td>
  </tr>
  <tr>
    <td>적응면역계 이상</td>
    <td>B cell 수 감소, 활성화 증가 / T cell 이상</td>
  </tr>
</tbody>
</table>

<p><br></p>
<h2 id="3">3. 임상증상</h2>
<h3 id="3-1">3-1. 관절증상</h3>
<ol>
<li>76~100%에서 발현 (가장 흔한 증상)</li>
<li>2개 이상의 관절에 swelling을 동반한 synovitis, 30분 이상의 조조강직. 골변형은 드물다.</li>
<li>과도한 운동성 병변 -&gt; Jaccoud’s arthropathy</li>
<li>AVN (+) : 고관절에 국한된 통증, 5~10%, 주로 GC 사용과 관련</li>
<li>Myositis : SLE itself or Drug (HCQ, GC)</li>
</ol>
<h3 id="3-2">3-2. 관절 외 증상</h3>
<table class=basic>
<thead>
  <tr>
    <th>System</th>
    <th>증상</th>
  </tr>
</thead>
<tbody>
  <tr>
    <td>피부증상</td>
    <td>ACLE (malar rash, photosensitivity), SCLE, CCLE (discoid rash, alopecia)</td>
  </tr>
  <tr>
    <td>점막증상</td>
    <td>구강, 코, 항문, 생식기, 혈관염 (두드러기, 자반, 손가락궤양, 홍반성 구진)</td>
  </tr>
  <tr>
    <td>뇌신경증상</td>
    <td>2/3에서 발생. neuro + psychiatric sx. 주로 seizure, headache 형태로 발생. Transverse&nbsp;&nbsp;&nbsp;myelitis</td>
  </tr>
  <tr>
    <td>혈액학적증상</td>
    <td>ACD, Lymphopenia, leukopenia, thrombocytopenia. 연관된 TTP/HUS, hemolytic&nbsp;&nbsp;&nbsp;anemia</td>
  </tr>
  <tr>
    <td>심폐증상</td>
    <td>pericarditis, myocarditis, Libman-Sacks endocarditis, CAD, Diffuse&nbsp;&nbsp;&nbsp;alveolar hemorrhage, shrinking lung syndrome, PAH</td>
  </tr>
  <tr>
    <td>신장증상</td>
    <td>Urine protein 500mg/d or dipstick 3+ or RBC casts</td>
  </tr>
  <tr>
    <td>위장관증상</td>
    <td>연하곤란, ascites, pancreatitis, serositis, protein-losing enteropathy</td>
  </tr>
  <tr>
    <td>간증상</td>
    <td>Budd-Chiari syndrome</td>
  </tr>
  <tr>
    <td>안과 증상</td>
    <td>sicca syndrome, 공막염, 시신경염, retinal toxicity (HCQ)</td>
  </tr>
  <tr>
    <td>장막염</td>
    <td>흉막염, 심장막염, 복막염 등</td>
  </tr>
</tbody>
</table>

<p><br></p>
<h2 id="4">4. 검사소견과 진단</h2>
<h3 id="4-1">4-1. 혈액/소변검사</h3>
<ol>
<li>CBC : ACD, Hemolytic anemia (direct Coomb’s test), leukopenia (lymphopenia), thrombocytopenia, HUS/TTP</li>
<li>Chemistry : routine + CRP (&lt;4~5mg/dl)</li>
<li>U/A : Urine protein 500mg/d or dipstick 3+ or RBC cast</li>
<li>Autoimmune markers : ANA 1:80, Anti-dsDNA, Anti-Sm, APS, etc.</li>
<li>Complement : C3, C4, CH50<ul>
<li><b>Ds. activity를 반영하는 검사 : Anti-dsDNA와 C3/C4/CH50 titer</b></li>
<li>호전 이후로도 dsDNA는 고역가로 보일 수도 있다.</li>
</ul>
</li>
</ol>
<h3 id="4-2">4-2. 조직검사</h3>
<ol>
<li>Skin : Immunoglobulin과 complement 구성요소들이 dermoepidermal junction을 따라 침착</li>
<li>Kidney : LN 분류, 다른 질환 감별, 치료, 예후와 관련</li>
</ol>
<h3 id="4-3">4-3. 분류기준</h3>
<details class="note"><summary>1997 ACR / 2012 SLICC SLE classification criteria</summary><div class="tabbed-set tabbed-alternate" data-tabs="1:2"><input checked="checked" id="__tabbed_1_1" name="__tabbed_1" type="radio" /><input id="__tabbed_1_2" name="__tabbed_1" type="radio" /><div class="tabbed-labels"><label for="__tabbed_1_1">ENG</label><label for="__tabbed_1_2">국문</label></div>
<div class="tabbed-content">
<div class="tabbed-block">
<p><table class="definition_sle">
 <thead>
 <tr class="score">
    <td colspan="2">1997 Updated of the 1982 ACR revised Criteria</td>
    <td colspan="2">2012 SLICC classification criteria</td>
 </tr>
 <tr>
    <td colspan="2"  style="vertical-align: top;">&#42; For the ACR criteria, no distinction is made between clinical and immunologic criteria in determining whether the required number has been met. The classification is based upon 11 criteria. For the purpose of identifying patients in clinical studies, a person is said to have SLE if any 4 or more of the 11 criteria are present, serially or simultaneously, during any interval of observation.</td>
    <td colspan="2" style="vertical-align: top;">¶ For the SLICC criteria, criteria are cumulative and need not be presently concurrently. A patient is classified as having SLE if he or she satisfies 4 of the clinical and immunologic criteria used in the SLICC classification criteria, including at least 1 clinical criterion and 1 immunologic criterion.<br><br>Δ Alternatively, according to the SLICC criteria, a patient is classified as having SLE if he or she has biopsy-proven nephritis compatible with SLE in the presence of ANAs or anti-dsDNA antibodies.
    </td>
 <tr>
 <tr class="score">
    <td colspan="2">(4 of 11 criteria)*</td>
    <td colspan="2">(4 of 17 criteria, including at least 1 clinical criterion and 1 immunologic criterion;¶ <br>OR biopsy-proven lupus nephritisΔ)</td>
 </tr>
 <tr>
    <td>Criterion</td>
    <td>Definition</td>
    <td>Criterion</td>
    <td>Definition</td>
 </tr>
 </thead>
 <tbody>
 <tr class="active-row">
    <td colspan="2"></td>
    <td colspan="2">Clinical criteria</td>
 </tr>
 <tr>
    <td>Malar rash</td>
    <td>Fixed erythema, flat or raised, over the malar eminences, tending to spare the nasolabial folds</td>
    <td rowspan="2">Acute cutaneous lupus</td>
    <td rowspan="2">Lupus malar rash (do not count if malar discoid); bullous lupus; toxic epidermal necrolysis variant of SLE; maculopapular lupus rash; photosensitive lupus rash (in the absence of dermatomyositis); OR subacute cutaneous lupus (nonindurated psoriaform and/or annular polycyclic lesions that resolve without scarring, although occasionally with postinflammatory dyspigmentation or telangiectasias)</td>
 </tr>
 <tr>
    <td>Photosensitivity</td>
    <td>Skin rash as a result of unusual reaction to sunlight, by patient history or clinician observation</td>
 </tr>
 <tr>
    <td>Discoid rash</td>
    <td>Erythematosus raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring may occur in older lesions</td>
    <td>Chronic cutaneous lupus</td>
    <td>Classic discoid rash; localized (above the neck); generalized (above and below the neck); hypertrophic (verrucous) lupus; lupus panniculitis (profundus); mucosal lupus; lupus erythematosus tumidus; chilblains lupus; OR discoid lupus/lichen planus overlap</td>
 </tr>
 <tr>
    <td></td>
    <td></td>
    <td>Nonscarring alopecia</td>
    <td>Diffuse thinning or hair fragility with visible broken hairs (in the absence of other causes, such as alopecia areata, drugs, iron deficiency, and androgenic alopecia)</td>
 </tr>
 <tr>
    <td>Oral ulcers</td>
    <td>Oral or nasopharyngeal ulceration, usually painless, observed by a clinician</td>
    <td>Oral or nasal ulcers</td>
    <td>Palate, buccal, tongue, OR nasal ulcers (in the absence of other causes, such as vasculitis, Behçet syndrome, infection [herpesvirus], inflammatory bowel disease, reactive arthritis, and acidic foods)</td>
 </tr>
 <tr>
    <td rowspan="2">Arthritis</td>
    <td rowspan="2">Nonerosive arthritis involving 2 or more peripheral joints, characterized by tenderness, swelling, or effusion</td>
    <td rowspan="2">Joint disease</td>
    <td>Synovitis involving 2 or more joints, characterized by swelling or effusion OR</td>
 </tr>
 <tr>
    <td>Tenderness in 2 or more joints and at least 30 minutes of morning stiffness</td>
 </tr>
 <tr>
    <td rowspan="2">Serositis</td>
    <td>Pleuritis – Convincing history of pleuritic pain or rubbing heard by a clinician or evidence of pleural effusion OR</td>
    <td rowspan="2">Serositis</td>
    <td>Typical pleurisy for more than 1 day, pleural effusions, or pleural rub, OR</td>
</tr>
<tr>
    <td>Pericarditis – Documented by ECG, rub, or evidence of pericardial effusion</td>
    <td>Typical pericardial pain (pain with recumbency improved by sitting forward) for more than 1 day, pericardial effusion, pericardial rub, or pericarditis by electrocardiography in the absence of other causes, such as infection, uremia, and Dressler syndrome</td>
 </tr>
 <tr>
    <td rowspan="2">Renal disorder</td>
    <td>Persistent proteinuria greater than 500 mg/24 hours or greater than 3+ if quantitation not performed OR</td>
    <td rowspan="2">Renal</td>
    <td>Urine protein-to-creatinine ratio (or 24-hour urine protein) representing 500 mg protein/24 hours, OR</td>
 </tr>
 <tr>
    <td>Cellular casts – May be red cell, hemoglobin, granular, tubular, or mixed</td>
    <td>Red blood cell casts</td>
 </tr>
 <tr>
    <td>Neurologic disorder</td>
    <td>Seizures OR psychosis – In the absence of offending drugs or known metabolic derangements (uremia, ketoacidosis, or electrolyte imbalance)</td>
    <td>Neurologic</td>
    <td>Seizures; psychosis; mononeuritis multiplex (in the absence of other known causes, such as primary vasculitis); myelitis; peripheral or cranial neuropathy (in the absence of other known causes, such as primary vasculitis, infection, and diabetes mellitus); OR acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs)</td>
</tr>
<tr>
    <td rowspan="4">Hematologic disorder</td>
    <td rowspan="4">Hemolytic anemia – With reticulocytosis OR<br>Leukopenia – Less than 4000/mm3 total on 2 or more occasions OR<br>Lymphopenia – Less than 1500/mm3 on 2 or more occasions OR<br>Thrombocytopenia – Less than 100,000/mm3 (in the absence of offending drugs)</td>
    <td>Hemolytic anemia</td>
    <td>Hemolytic anemia</td>
 </tr>
 <tr>
    <td rowspan="2">Leukopenia or lymphopenia</td>
    <td>Leukopenia (&lt;4000/mm3 at least once) (in the absence of other known causes, such as Felty syndrome, drugs, and portal hypertension), OR</td>
 </tr>
 <tr>
    <td>Lymphopenia (&lt;1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection)</td>
 </tr>
 <tr>
    <td>Thrombocytopenia</td>
    <td>Thrombocytopenia (&lt;100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura</td>
 </tr>
 <tr class="active-row">
    <td colspan="2"></td>
    <td colspan="2">Immunologic criteria</td>
 </tr>
 <tr>
    <td>ANA</td>
    <td>An abnormal titer of ANA by immunofluorescence or an equivalent assay at any point in time and in the absence of drugs known to be associated with "drug-induced lupus" syndrome</td>
    <td>ANA</td>
    <td>ANA level above laboratory reference range</td>
 </tr>
 <tr>
    <td rowspan="3">Immunologic disorders</td>
    <td rowspan="3">Anti-DNA – Antibody to native DNA in abnormal titer OR<br>Anti-Sm – Presence of antibody to Sm nuclear antigen OR<br>Positive antiphospholipid antibody on:<br>An abnormal serum level of IgG or IgM anticardiolipin antibodies OR<br>A positive test result for lupus anticoagulant using a standard method OR<br>A false-positive serologic test for syphilis known to be positive for at least 6 months and confirmed by Treponema pallidum immobilization or fluorescent treponemal antibody absorption test</td>
    <td>Anti-dsDNA</td>
    <td>Anti-dsDNA antibody level above laboratory reference range (or &gt;2-fold the reference range if tested by ELISA)</td>
 </tr>
 <tr>
    <td>Anti-Sm</td>
    <td>Presence of antibody to Sm nuclear antigen</td>
 </tr>
 <tr>
    <td>Antiphospholipid</td>
    <td>Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant; false-positive test result for rapid plasma reagin; medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM); or positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM)</td>
 </tr>
 <tr>
    <td></td>
    <td></td>
    <td>Low complement</td>
    <td>Low C3; low C4; OR low CH50</td>
 </tr>
 <tr>
    <td></td>
    <td></td>
    <td>Direct Coombs test</td>
    <td>Direct Coombs test in the absence of hemolytic anemia</td>
 </tr>
 </tbody>
 </table></p>
</div>
<div class="tabbed-block">
<p><table class="definition_sle">
 <colgroup>
 <col width=12%>
 <col width=38%>
 <col width=12%>
 <col width=38%>
 </colgroup>
 <thead>
 <tr class="score">
    <td colspan="2">1997 업데이트된 1982 ACR 개정 기준</td>
    <td colspan="2">2012 SLICC 분류기준</td>
 </tr>
 <tr>
    <td colspan="2"  style="vertical-align: top;">&#42; ACR 분류기준의 경우 필요한 수를 충족했는지 여부를 결정할 때 임상 기준과 면역학적 기준을 구분하지 않는다. 11가지 기준에 따라 분류된다. 임상 연구에서 환자를 식별할 목적으로, 관찰 기간 동안 11개 기준 중 4개 이상이 연속적으로 또는 동시에 존재할 경우 SLE가 있는 사람이라고 한다.</td>
    <td colspan="2" style="vertical-align: top;">¶ SLICC 분류기준의 경우 기준은 누적되며 평가하는 시점에 증상이 동시에 있을 필요는 없다. 환자는 SLICC 분류 기준에서 사용되는 임상 및 면역학적 기준 중 1개 이상의 임상 기준 및 1개의 면역학적 기준을 포함하여 4가지를 충족하는 경우 SLE가 있는 것으로 분류된다.<br><br>Δ 또는, SLICC 기준에 따르면, 환자가 ANA 또는 Anti-dsDNA가 있는 상태에서 SLE에 합당한 조직검사로 확인된 신염이 있는 경우에 SLE가 있다고 분류된다.
    </td>
 <tr>
 <tr class="score">
    <td colspan="2">(11개 중 4개 기준)*</td>
    <td colspan="2">(17개 중 4개 기준, 최소 1개의 임상 기준과 1개의 면역학적 기준을 포함한다;¶ 또는 조직검사로 확인된 루푸스신염Δ)</td>
 </tr>
 <tr>
    <td>기준</td>
    <td>정의</td>
    <td>기준</td>
    <td>정의</td>
 </tr>
 </thead>
 <tbody>
 <tr class="active-row">
    <td colspan="2"></td>
    <td colspan="2">임상 기준</td>
 </tr>
 <tr>
    <td>빰 발진</td>
    <td>고정된 홍반, 평탄하거나 융기되어있고, 뺨 부위에 걸쳐있는데, 대개 코입술주름은 침범하지 않음</td>
    <td rowspan="2">급성 피부 루푸스</td>
    <td rowspan="2">루푸스 뺨 발진 (do not count if malar discoid); bullous lupus; toxic epidermal necrolysis variant of SLE; maculopapular lupus rash; photosensitive lupus rash (in the absence of dermatomyositis); OR subacute cutaneous lupus (nonindurated psoriaform and/or annular polycyclic lesions that resolve without scarring, although occasionally with postinflammatory dyspigmentation or telangiectasias)</td>
 </tr>
 <tr>
    <td>광과민성</td>
    <td>햇빛에 대한 비정상적인 반응의 결과로 발생한 피부발진으로, 환자의 병력이나 의사의 진찰로 확인</td>
 </tr>
 <tr>
    <td>원반형<br>발진</td>
    <td>각화된 비늘이 붙어 있고 모낭선이 막혀 있는 도드라진 홍반; 오래된 병변에서는 위축성 반흔이 발생할 수 있음</td>
    <td>만성 피부 루푸스</td>
    <td>전통적인 원반형 발진; 국소적 (목 위); 전신적 (목 위와 아래); hypertrophic (verrucous) lupus; lupus panniculitis (profundus); mucosal lupus; lupus erythematosus tumidus; chilblains lupus; OR discoid lupus/lichen planus overlap</td>
 </tr>
 <tr>
    <td></td>
    <td></td>
    <td>흉터 없는 탈모</td>
    <td>머리카락이 눈에 띄게 가늘어지거나 약해짐(원형 탈모증, 약물, 철 결핍증, 안드로겐성 탈모와 같은 다른 원인이 없는 경우)</td>
 </tr>
 <tr>
    <td>구강 궤양</td>
    <td>구강 혹은 비인두 궤양, 흔히 통증이 없으며 의사에 의해 확인</td>
    <td>구강 또는 <br>비강 궤양</td>
    <td>입천장, 볼, 혀 또는 비강 궤양 (혈관염, 베쳇 증후군, 감염[헤르페스 바이러스], 염증성 장질환, 반응성 관절염 및 산성 식품 등의 다른 원인이 없는 경우)</td>
 </tr>
 <tr>
    <td rowspan="2">관절염</td>
    <td rowspan="2">2개 이상의 말초 관절을 침범하는 비미란성 관절염으로 압통, 부종, 삼출액을 동반한 경우</td>
    <td rowspan="2">관절질환</td>
    <td>부종이나 삼출액을 동반한 2개 이상 관절의 활막염 또는</td>
 </tr>
 <tr>
    <td>2개 이상 관절의 압통과 최소 30분 이상의 조조강직</td>
 </tr>
 <tr>
    <td rowspan="2">장막염</td>
    <td>흉막염 – 늑막통증의 명확한 병력 또는 의사가 청진으로 확인한 마찰음 또는 흉막삼출액의 증거 또는</td>
    <td rowspan="2">장막염</td>
    <td>1일 이상의 전형적인 흉막염, 흉막삼출 또는 흉막잡음 또는</td>
</tr>
<tr>
    <td>심장막염 – 심전도, 청진된 마찰음, 또는 심낭액의 증거가 있는 경우</td>
    <td>1일 이상의 전형적인 심막통증 (누울 때는 통증이 있는데 앉은자세에서 호전), 심낭액, 심낭마찰음, 또는 감염, 요독, Dressler syndrome과 같은 다른 원인이 없는 상태에서 심초음파로 확인된 심장막염</td>
 </tr>
 <tr>
    <td rowspan="2">신장질환</td>
    <td>지속적인 단백뇨 (&gt;500mg/일 또는 정량을 하지 않았다면 3+) 또는</td>
    <td rowspan="2">신장</td>
    <td>UPCR (또는 24시간 소변 단백량)이 500mg 단백/24시간 을 나타내거나, 또는</td>
 </tr>
 <tr>
    <td>세포성 원주 – 적혈구, 혈색소, 백혈구, 또는 혼합형 원주일 수 있음</td>
    <td>적혈구 원주</td>
 </tr>
 <tr>
    <td>신경질환</td>
    <td>발작이나 정신병 - 원인약물이나 알려진 대사이상 (요독, 케톤산증, 전해질이상)이 없이 발생</td>
    <td>신경</td>
    <td>발작; 정신병; 다발성단일신경염 (혈관염과 같은 다른 원인 없음); 척수염; 말초 혹은 중추성 신경증 (혈관염, 감염, 당뇨와 같은 다른 원인 없음); 또는 급성 혼동 상태 (독소/대사, 요독, 약물과 같은 다른 원인 없음)</td>
</tr>
<tr>
    <td rowspan="4">혈액질환</td>
    <td rowspan="4">용혈빈혈 – 망상적혈구증(Reticulocytosis)이 있거나 또는<br>백혈구감소증 – 2회 이상 4000/mm3 미만 또는<br>림프구감소증 – 2회 이상 1500/mm3 미만 또는 <br>혈소판감소증 – 100,000/mm3 미만 (원인약물 없이)</td>
    <td>용혈빈혈</td>
    <td>용혈빈혈</td>
 </tr>
 <tr>
    <td rowspan="2">백혈구감소증 or 림프구감소증</td>
    <td>백혈구감소증 (최소 1회 &lt;4000/mm3) (Felty syndrome이나, 약물, 문맥고혈압 등의 다른 원인 없이), 또는</td>
 </tr>
 <tr>
    <td>림프구감소증 (최소 1회 &lt;1000/mm3) (글루코코르티코이드, 약물, 감염 등의 다른 원인 없이)</td>
 </tr>
 <tr>
    <td>혈소판감소증</td>
    <td>혈소판감소증 (최소 1회 &lt;100,000/mm3) (약물, 문맥고혈압, TTP 등의 다른 원인 없이)</td>
 </tr>
 <tr class="active-row">
    <td colspan="2"></td>
    <td colspan="2">면역학적 기준</td>
 </tr>
 <tr>
    <td>ANA</td>
    <td>질환의 어느 시점에서든 면역형광법 또는 이에 상응하는 검사에 의한 ANA의 비정상적인 역가 ("약물 유발 루푸스" 증후군과 관련이 있는 것으로 알려진 약물이 없어야 함)</td>
    <td>ANA</td>
    <td>ANA 수치가 검사실 기준치보다 높을 떄</td>
 </tr>
 <tr>
    <td rowspan="3">면역학적 질환</td>
    <td rowspan="3">Anti-DNA – 항 DNA항체의 비정상 역가 또는<br>Anti-Sm – Sm nuclear antigen에 대한 항체 양성 또는<br>항인지질항체 양성:IgG 또는 IgM anticardiolipin 항체의 비정상 수치 또는 표준화된 검사법을 사용하여 검사한 lupus anticoagulant 양성 또는<br>매독검사 위양성 (최소 6개월 지속되고 TPI나 FTA-ABS 검사로 확인됨)</td>
    <td>Anti-dsDNA</td>
    <td>Anti-dsDNA antibody 수치가 검사실 기준치보다 높은 경우(또는 ELISA로 검사했을 때 검사 기준치의 2배를 초과하는 경우)</td>
 </tr>
 <tr>
    <td>Anti-Sm</td>
    <td>Sm nuclear antigen에 대한 항체 양성</td>
 </tr>
 <tr>
    <td>Antiphospholipid</td>
    <td>항인지질항체가 다음 중 어느 것으로든 확인되는 경우: lupus anticoagulant 양성; RPR 위양성; 중간 또는 고역가의 anticardiolipin antibody level (IgA, IgG, or IgM); 또는 anti-beta 2-glycoprotein I (IgA, IgG, or IgM) 양성</td>
 </tr>
 <tr>
    <td></td>
    <td></td>
    <td>낮은 보체</td>
    <td>낮은 C3; 낮은 C4; 또는 낮은 CH50</td>
 </tr>
 <tr>
    <td></td>
    <td></td>
    <td>Direct Coombs test</td>
    <td>용혈빈혈이 없는 상태에서 Direct Coombs test 양성</td>
 </tr>
 </tbody>
 </table></p>
</div>
</div>
</div>
</details>
<details class="note"><summary>2019 ACR/EULAR SLE classification criteria</summary><div class="tabbed-set tabbed-alternate" data-tabs="2:2"><input checked="checked" id="__tabbed_2_1" name="__tabbed_2" type="radio" /><input id="__tabbed_2_2" name="__tabbed_2" type="radio" /><div class="tabbed-labels"><label for="__tabbed_2_1">ENG</label><label for="__tabbed_2_2">국문</label></div>
<div class="tabbed-content">
<div class="tabbed-block"></div>
<div class="tabbed-block"></div>
</div>
</div>
</details>
<h3 id="4-4">4-4. 감별진단</h3>
<p><br></p>
<h2 id="5">5. 치료원칙</h2>
<h3 id="5-1">5-1. 개념 요약</h3>
<ol>
<li>관해 도달 or 낮은 질병활성도 유지가 목표</li>
<li>질병활성도 평가가 중요 : 증상, P/E, Lab, Anti-dsDNA, Complement, SLEDAI</li>
<li>비약물요법 : 일광차단, 금연, 적절한 영양공급, 운동, 예방접종</li>
<li>약물요법 : HCQ, Low dose GC, Immunosuppressant</li>
<li>기타 증상에 맞는 치료</li>
<li>Dyslipidemia, DM, HTN, Osteoporosis 관리, Cancer screening</li>
<li>임신 전 Ro/La 평가, 6개월 이상 remission state여야 한다. PRD, AZA, HCQ, ASA는 사용 가능, Congenital heart block 고려</li>
</ol>
<h3 id="5-2">5-2. 가이드라인</h3>
<h3 id="5-3-disease-activity-assessment">5-3. Disease activity assessment</h3>
<ol>
<li>기본 개념<ol>
<li>single summary score system : SLEDAI, SLAM 등</li>
<li>Organ-specific score system : BILAG</li>
</ol>
</li>
<li>SLEDAI<ol>
<li>최근 10일 동안의 질병활성도 평가 (6점 이상이면 중등도, 20점 이상이면 고중증)</li>
<li>SLEDAI-2K, SELENA-SLEDAI</li>
<li>가장 간단하고 쉽지만 기존 증상의 악화나 일부 호전을 민감하게 평가하기 어렵고 증상 중증도에 따른 가중치가 없다.</li>
</ol>
</li>
<li>BILAG<ol>
<li>9개 organ system에 대한 지표 (2004), 최근 4주간의 질병활성도를 지난 4주간의 활성도와 비교</li>
<li>각 organ system 활성도를 A ~ E로 평가 (A가 제일 높은 활성도)</li>
<li>Severe : A로 바뀔 때. Moderate : B로 바뀔 때. Effect : A &amp; B가 없을 떄</li>
<li>가장 포괄적이고 질병활성도/중증도를 감별할 수 있으며 민감도가 높으나, 실제 임상에서 쓰기에는 평가 항목이 많고 복잡하다.</li>
</ol>
</li>
<li>기타 지표<ol>
<li>SLAM-R (2001) : 최근 4주간의 질병활성도 측정</li>
<li>ECLAM, LAI, SLAQ 등도 있다.</li>
</ol>
</li>
</ol>
<h3 id="5-4-damage-assessment">5-4. Damage assessment</h3>
<ol>
<li>SLICC/ACR-DI<ol>
<li>손상 : 6개월 이상 지속되거나 병리학적 반흔이 동반된 비가역적 증상</li>
<li>12개 장기 시스템에 대한 41개 평가항목, 0~46점</li>
<li>사망률 예측과 예후 판정에 도움</li>
</ol>
</li>
<li>LDIQ (설문지)</li>
<li>BILD (설문지)</li>
</ol>
<h2 id="6">6. 경과와 예후</h2>
<h3 id="6-1">6-1. 예후</h3>
<ul>
<li>고연령, 남성, 미국 흑인, 높은 SLEDAI, GC 사용, HTN 있을 때 기관 손상이 많이 발생</li>
<li>기관손상이 있으면 사망률은 1.46배 증가</li>
<li>SLE 환자는 일반인에 비해 사망률 3~5배 증가, 주요 사망 원인은 LN, 높은 SLEDAI, 감염, 심혈관계 질환 등</li>
</ul>
                
                  
                    

<hr>
<div class="md-source-date">
  <small>
    
      Last update: <span class="git-revision-date-localized-plugin git-revision-date-localized-plugin-date">November 1, 2021</span>
      
    
  </small>
</div>
                  
                
              
              
                


              
            </article>
          </div>
        </div>
        
          <a href="#" class="md-top md-icon" data-md-component="top" data-md-state="hidden">
            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12z"/></svg>
            Back to top
          </a>
        
      </main>
      
        
<footer class="md-footer">
  
    <nav class="md-footer__inner md-grid" aria-label="Footer">
      
        
        <a href="../../ra/ra/" class="md-footer__link md-footer__link--prev" aria-label="Previous: Rheumatoid Arthritis" rel="prev">
          <div class="md-footer__button md-icon">
            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12z"/></svg>
          </div>
          <div class="md-footer__title">
            <div class="md-ellipsis">
              <span class="md-footer__direction">
                Previous
              </span>
              Rheumatoid Arthritis
            </div>
          </div>
        </a>
      
      
        
        <a href="../aps/" class="md-footer__link md-footer__link--next" aria-label="Next: APS" rel="next">
          <div class="md-footer__title">
            <div class="md-ellipsis">
              <span class="md-footer__direction">
                Next
              </span>
              APS
            </div>
          </div>
          <div class="md-footer__button md-icon">
            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M4 11v2h12l-5.5 5.5 1.42 1.42L19.84 12l-7.92-7.92L10.5 5.5 16 11H4z"/></svg>
          </div>
        </a>
      
    </nav>
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-footer-copyright">
        
        
          Made with
          <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
            Material for MkDocs
          </a>
        
        
      </div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    <script id="__config" type="application/json">{"base": "../..", "features": ["navigation.tabs", "navigation.indexes", "navigation.top"], "translations": {"clipboard.copy": "Copy to clipboard", "clipboard.copied": "Copied to clipboard", "search.config.lang": "en", "search.config.pipeline": "trimmer, stopWordFilter", "search.config.separator": "[\\s\\-]+", "search.placeholder": "Search", "search.result.placeholder": "Type to start searching", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.term.missing": "Missing", "select.version.title": "Select version"}, "search": "../../assets/javascripts/workers/search.8397ff9e.min.js", "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.1e84347e.min.js"></script>
      
    
  </body>
</html>